Hyosung Chemical Corp

Hyosung Chemical Corp's capital structure is highly leveraged, with a debt-to-equity ratio of 4.35, indicating significant reliance on debt financing. The company's liquidity position is weak, as evidenced by a current ratio of 0.41 and negative free cash flow of -90.33 billion KRW. Despite a market price of 38,900 KRW per share, the price-to-book ratio of 0.4 and price-to-tangible-book ratio of 0.4 suggest the company is trading at a substantial discount to its book value. Profitability metrics are mixed. The company reported a net income of 393.10 billion KRW, but this was driven by non-operating gains, as operating income was -182.96 billion KRW. Return on equity (ROE) of 1.06% and return on assets (ROA) of 0.15% are below the industry median for Commodity Chemicals, indicating underperformance relative to peers. The company's revenue is concentrated in a few product lines, with polypropylene (PP), TPA, and NF3 gas representing the majority of its sales. Geographic exposure is primarily domestic, with limited international revenue disclosed in the financial snapshot. This concentration increases vulnerability to regional demand shifts and raw material price volatility. Growth trajectory is uncertain. The company's operating cash flow is negative (-85.02 billion KRW), and capital expenditures of -44.00 billion KRW suggest ongoing investment in operations. However, without a clear revenue growth path or margin expansion, the company's ability to sustain operations is questionable. Risk factors include high leverage and weak liquidity. The company's net cash position is negative after subtracting total debt, and its liquidity risk is rated as medium. Dilution risk is low, but the company's reliance on long-term debt (1.61 trillion KRW) exposes it to interest rate and refinancing risks. Recent events include a significant net income driven by non-operating gains, which may not be sustainable. The company's operating losses and negative cash flows highlight the need for operational improvements or strategic restructuring.